Ann: Top-line Results from the Phase 3 AEGIS-II Trial, page-3

  1. 5,009 Posts.
    lightbulb Created with Sketch. 255
    "Investors will be aware that CSL has excluded any financial contribution from CSL112 in itsforward-looking estimates and statements. Further, CSL does not expect any material financialimpact following the AEGIS-II trial conclusion."

    Might be a good day for long term holders to top up.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$256.02
Change
7.630(3.07%)
Mkt cap ! $122.7B
Open High Low Value Volume
$252.00 $256.08 $251.10 $201.6M 781.6K

Buyers (Bids)

No. Vol. Price($)
5 27 $256.02
 

Sellers (Offers)

Price($) Vol. No.
$256.09 17 5
View Market Depth
Last trade - 11.20am 18/07/2025 (20 minute delay) ?
CSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.